SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Schiehalli. Regulatory News (MNTN)

Share Price Information for The Schiehalli. (MNTN)

Share Price is delayed by 15 minutes
Get Live Data
2.17    0.02 (0.93%)
Bid:
2.18
Ask:
2.20
Spread: 0.02 (0.917%)
Market Cap: $2.23b
MNTN Live PriceLast checked at - London Stock Exchange

Intraday The Schiehalli. Share Chart

C Share Conversion Ratio

7 Sep 2023 12:25

RNS Number : 7522L
Schiehallion Fund Limited (The)
07 September 2023
 

The Schiehallion Fund Limited

(the "Company")

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

C Share Conversion Ratio

Further to the announcement on 3 August 2023, the Company is pleased to announce the Conversion Ratio on the basis of the respective Net Asset Values of the Ordinary Shares and the C Shares as at the Conversion Calculation Date, being 31 August 2023.

 

 

Net Asset Value per Ordinary Share

106.14 cents

Net Asset Value per C Share

80.68 cents

Conversion Ratio

0.7601 Ordinary shares for each C Share

 

 

The number of New Ordinary Shares to be issued as a result of Conversion will be calculated based on the register at 6.00 p.m. on 8 September 2023 and is expected to be announced on 11 September 2023. The holders of C Shares will not be entitled to fractions of New Ordinary Shares arising on Conversion. Instead, the number of New Ordinary Shares to be issued to each holder will be rounded down to the nearest whole number of Ordinary Shares and fractional entitlements will be disregarded, with any value attributable to them being retained for the benefit of the Company. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares, including the right to receive all future dividends or distributions declared in respect of the Ordinary Shares.

 

Application has been made for the New Ordinary Shares to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market ("Admission"). It is now expected that admission will become effective and that dealings in the New Ordinary Shares will commence at 8:00 a.m. on 12 September 2023 (rather than 11 September 2023, as indicated in the announcement on 3 August 2023).

 

Application will also be made to cancel the C Shares from trading on the London Stock Exchange as soon as reasonably practicable following Conversion.

 

 

 

Expected timetable

 

Event

Date

Conversion record date

6:00 p.m. on 8 September 2023

Cancellation of C Shares

As soon as reasonably practicable following conversion

Admission of new Ordinary Shares on Conversion and dealings commence

 

8:00 a.m. on 12 September 2023

Crediting of CREST accounts with new Ordinary Shares

12 September 2023

Share Certificates in respect of new Ordinary Shares despatched

w/c 18 September 2023

 

 

Capitalised terms used but not defined in this announcement will have the same meaning as set out in the Prospectus.

 

 

 

 

Baillie Gifford & Co Limited

7 September 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBUAROUUKRAR
Date   Source Headline
30th Aug 202212:17 pmRNSNet Asset Value(s)
12th Aug 202212:54 pmRNSNet Asset Value(s)
1st Aug 20222:30 pmRNSClosed Period Confirmation
1st Aug 202212:03 pmRNSNet Asset Value(s)
21st Jul 202210:54 amRNSNet Asset Value(s)
1st Jul 202212:30 pmRNSNet Asset Value(s)
1st Jun 202212:04 pmRNSNet Asset Value(s)
24th May 202211:24 amRNSDirector/PDMR Shareholding
23rd May 20229:52 amRNSDirector/PDMR Shareholding
20th May 20229:40 amRNSDirector/PDMR Shareholding
18th May 20222:59 pmRNSDirector/PDMR Shareholding Yueh
17th May 20222:28 pmRNSDirector/PDMR Shareholding
16th May 20224:10 pmRNSDirector/PDMR Shareholding
16th May 20229:53 amRNSDirector/PDMR Shareholding
12th May 202212:53 pmRNSResult of AGM
11th May 202212:31 pmRNSNet Asset Value(s)
3rd May 202212:47 pmRNSNet Asset Value(s)
28th Apr 202212:43 pmRNSNet Asset Value(s)
28th Apr 20229:00 amRNSBlock listing Interim Review
19th Apr 202212:17 pmRNSNet Asset Value(s)
4th Apr 202211:44 amRNSAnnual Financial Report
1st Apr 20222:04 pmRNSNet Asset Value(s)
29th Mar 20227:00 amRNSFinal Results
24th Mar 202212:29 pmRNSNet Asset Value(s)
8th Mar 202211:39 amRNSNet Asset Value(s)
1st Mar 20222:17 pmRNSNet Asset Value(s)
24th Feb 202211:47 amRNSNet Asset Value(s) - REPLACEMENT
24th Feb 202211:27 amRNSNet Asset Value(s)
14th Feb 20222:23 pmRNSNet Asset Value(s)
2nd Feb 202210:18 amRNSClosed Period Confirmation
1st Feb 20223:02 pmRNSNet Asset Value(s)
27th Jan 20223:06 pmRNSNet Asset Value(s)
19th Jan 20221:29 pmRNSNet Asset Value(s)
6th Jan 20221:30 pmRNSNet Asset Value(s)
4th Jan 20223:04 pmRNSTotal Voting Rights
4th Jan 20222:19 pmRNSNet Asset Value(s)
15th Dec 20211:28 pmRNSNet Asset Value(s)
9th Dec 20214:44 pmRNSIssue of Equity
9th Dec 202112:47 pmRNSNet Asset Value(s)
6th Dec 20211:48 pmRNSNet Asset Value(s)
1st Dec 20213:12 pmRNSNet Asset Value(s)
1st Dec 202110:29 amRNSTotal Voting Rights
29th Nov 20214:22 pmRNSIssue of Equity
24th Nov 20211:19 pmRNSNet Asset Value(s)
22nd Nov 20214:40 pmRNSHolding(s) in Company
22nd Nov 20213:30 pmRNSIssue of Equity
19th Nov 20214:36 pmRNSIssue of Equity
18th Nov 20219:39 amRNSIssue of Equity
16th Nov 20214:45 pmRNSIssue of Equity
15th Nov 20214:03 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.